SCHEMBL4694032

SCHEMBL4694032

N#Cc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)nc1OCCN1CCCC1I

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.38
MCHR1 Q99705 2/20 0.38
HTR2A P28223 1/20 0.38
HRH3 Q9Y5N1 6/20 0.36
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
KDM1A O60341 1/20 0.35
NPSR1 Q6W5P4 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 2/20 0.34
PKM P14618 1/20 0.34
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CHRNB1 P11230 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5520596 0.82 HRH3 (0.54) CHRM1MCHR1HTR2AHRH3
SCHEMBL4690341 0.77 SIGMAR1 (0.47) HRH3CNR1CNR2ALDH1A1KDM4E
SCHEMBL4696246 0.76 SGK1 (0.48) HRH3NPSR1ALDH1A1HPGDKDM4E
SCHEMBL14545311 0.76 CNR1 (0.40) HRH3CNR1KDM1AALDH1A1HPGD
SCHEMBL4695659 0.75 USP8 (0.40) HRH3CNR1CNR2KDM1AALDH1A1
SCHEMBL4747833 0.73 USP8 (0.57) CNR1CNR2ALDH1A1HPGDKDM4E
SCHEMBL5530945 0.71 ALDH1A1 (0.53) CNR1CNR2NPSR1ALDH1A1HPGD
SCHEMBL5521872 0.70 USP8 (0.43) CNR1CNR2ALDH1A1HPGDKDM4E
SCHEMBL14523435 0.69 CNR1 (0.40) CNR1NPSR1ALDH1A1HPGDKDM4E
SCHEMBL4695206 0.68 CNR1 (0.46) CNR1CNR2ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871762-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2008-01-02 EP disclosed
WO-2006113704-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2006-10-26 WO disclosed